Although sensitivity to TRAIL has been shown to be restored in TRAIL-resistant cancer cells following chemotherapy and radiation therapy [21, 22], the sensitivity of TRAIL-resistant cancer cells has also been shown to be altered through regulation of c-Met, which can lead to the eventual triggering of TRAIL-induced apoptosis. Here, MET is linked to cancer.